FoxBio Company
FoxBio, Inc. is a joint venture of Antoxerene, Inc., a portfolio company of Ichor Therapeutics, Inc., focused on small molecule drug discovery for pathways of aging, with Juvenescence Limited. FoxBio is a developer of a small molecules techniques intended to reduce senescent cells in human bodies. The company's techniques targets the pro-survival pathways of senescent cells to remove them from the body, enabling patients to have multiple health benefits and delay the onset of age related diseases.
Technology:
Geroscience
Industry:
Small&Large Molecules
Headquarters:
Lafayette, Louisiana, United States
Founded Date:
2018
Investors Number:
2
Total Funding:
10000000
Last Funding Date:
2018
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership